Live Breaking News & Updates on Vest Asset Management

Stay updated with breaking news from Vest asset management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Teva Pharmaceutical Industries (NYSE:TEVA) Hits New 12-Month High at $17.54

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) hit a new 52-week high on Tuesday . The company traded as high as $17.54 and last traded at $17.51, with a volume of 6441192 shares changing hands. The stock had previously closed at $16.85. Wall Street Analyst Weigh In TEVA has been the topic of […] ....

United-states , Israel , America , Amir-weiss , Piper-sandler , Vikkil-conway , Dekabank-deutsche-girozentrale , Jpmorgan-chase-co , Clarivest-asset-management , News-ratings-for-teva-pharmaceutical-industries-daily , Teva-pharmaceutical-industries-limited , Teva-pharmaceutical-industries

Fund 1 Investments LLC Has $2.92 Million Stake in PetIQ, Inc. (NASDAQ:PETQ)

Fund 1 Investments LLC lowered its position in PetIQ, Inc. (NASDAQ:PETQ – Free Report) by 11.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 147,645 shares of the company’s stock after selling 18,355 shares during the period. PetIQ accounts for 0.3% of Fund 1 Investments […] ....

Switzerland , United-states , Swiss , Clarivest-asset-management , Swiss-national-bank , Petiq-inc , Jefferies-financial-group , Dimensional-fund-advisors , Nasdaq , Vanguard-group-inc , Free-report

Cyrus Harmon Sells 5,000 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Stock

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) Director Cyrus Harmon sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $10.93, for a total value of $54,650.00. Following the completion of the transaction, the director now owns 786,283 shares […] ....

Cyrus-harmon , Clarivest-asset-management , Silverarc-capital-management , Goldman-sachs-group , Olema-pharmaceuticals , Quarter-for-olema-pharmaceuticals , Victory-capital-management-inc , News-ratings-for-olema-pharmaceuticals-daily , Nasdaq , Vivo-capital , Olema-pharmaceuticals-inc , Institutional-investors-weigh-in-on-olema-pharmaceuticals

Short Interest in Holley Inc. (NYSE:HLLY) Rises By 10.4%

Holley Inc. (NYSE:HLLY – Get Free Report) saw a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 2,550,000 shares, a growth of 10.4% from the April 30th total of 2,310,000 shares. Based on an average daily trading volume, of 285,500 shares, the days-to-cover ratio […] ....

Bamco , Xizang , China , United-states , Canada , Graham-clempson , Jpmorgan-chase-co , Clarivest-asset-management , Norden-group , Telsey-advisory-group , Holley-inc , Securities-exchange-commission

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Sees Large Decline in Short Interest

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) was the target of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 204,400 shares, a decrease of 11.1% from the April 30th total of 229,900 shares. Based on an average daily volume of 159,600 shares, […] ....

Great-lakes , Canada-general , Canada , United-states , Jamesg-marken , Skandinaviska-enskilda-banken , Stephenp-carey , Nasdaq , Pharmaceuticals-daily , Ani-pharmaceuticals-inc , Global-alpha-capital-management-ltd , Clarivest-asset-management